Education
About Us
Working with TipRanks
Follow Us
Paxman AB (PXMBF)
OTHER OTC:PXMBF
PXMBF Stock Chart & Stats
$3.50
$0.00(0.00%)
At close: 4:00 PM EDT
$3.50
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$3.50 - $3.50
Previous CloseN/A
Volume298.00
Average Volume (3M)0.00
Market Cap
$131.33M
Enterprise Value$1.05B
Total Cash (Recent Filing)$120.83M
Total Debt (Recent Filing)$13.01M
Price to Earnings (P/E)―
Beta0.00
Next Earnings
May 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding23,273,417
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.54
Price to Book (P/B)3.05
Price to Sales (P/S)3.95
P/FCF Ratio-145.60
Enterprise Value/Market Cap8.02
Enterprise Value/Revenue3.36
Enterprise Value/Gross Profit7.04
Enterprise Value/Ebitda36.44
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.2
Revenue Forecast (FY)$50.82M
Bulls Say, Bears Say
Bulls Say
Recurring Revenue ModelThe business derives recurring revenue from consumables, service and leases tied to an installed base. This creates durable revenue visibility and customer stickiness: as placements grow, repeat consumable and service sales provide predictable cash flow and leverage installed units for long-term margins.
Low Leverage And Larger Equity CushionVery low debt and a material increase in equity provide balance-sheet resilience, lowering solvency risk and preserving strategic optionality. This financial flexibility supports investment in placements, R&D or geographic expansion without immediate reliance on costly external funding.
Sustained Revenue GrowthConsistent top-line growth over multiple years shows ongoing market demand and adoption of Paxman systems. Continued revenue expansion sustains installed-base growth, which in turn fuels recurring consumable and service sales and supports scalable long-term revenue generation.
Bears Say
Sharp Gross Margin CollapseA sudden collapse in gross margin materially weakens the core economics of product sales and consumables. If structural (pricing pressure, cost increases or mix shifts), it undermines profitability of the recurring revenue model, reduces reinvestment capacity and prolongs weak returns until margins are restored.
Inconsistent Cash Generation & Negative FCFRepeated negative free cash flow and volatile operating cash flow limit the firm's ability to self-fund growth and maintenance of the installed base. Sustained negative FCF increases reliance on external financing, raising execution risk on expansion and potentially pressuring service and consumable investments.
Return On Equity Turned NegativeNegative ROE signals the company is destroying shareholder value currently, reflecting profitability and efficiency shortfalls. Persistently negative returns make it harder to justify capital allocation, can deter investors, and may constrain long-term growth if not corrected by margin or profit recovery.
Paxman AB News
PXMBF FAQ
What was Paxman AB’s price range in the past 12 months?
Paxman AB lowest stock price was $3.50 and its highest was $3.50 in the past 12 months.
What is Paxman AB’s market cap?
Paxman AB’s market cap is $131.33M.
When is Paxman AB’s upcoming earnings report date?
Paxman AB’s upcoming earnings report date is May 27, 2026 which is in 81 days.
How were Paxman AB’s earnings last quarter?
Paxman AB released its earnings results on Feb 27, 2026. The company reported -$0.044 earnings per share for the quarter, missing the consensus estimate of $0 by -$0.044.
Is Paxman AB overvalued?
According to Wall Street analysts Paxman AB’s price is currently Overvalued.
Does Paxman AB pay dividends?
Paxman AB does not currently pay dividends.
What is Paxman AB’s EPS estimate?
Paxman AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Paxman AB have?
Paxman AB has 23,273,417 shares outstanding.
What happened to Paxman AB’s price movement after its last earnings report?
Paxman AB reported an EPS of -$0.044 in its last earnings report, missing expectations of $0. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Paxman AB?
Currently, no hedge funds are holding shares in PXMBF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Paxman AB
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment in Europe, the United States, Mexico, Japan, Oceania, rest of Asia, and South and Central America. It serves various cancer centers and hospitals. The comapny has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device. Paxman AB (publ) was founded in 1996 and is based in Karlshamn, Sweden.
PXMBF Earnings Call
Q4 2026
0:00 / 0:00